Search Results

Filter
  • 1-10 of  63 results for ""Respiratory Syncytial Virus Vaccines""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Concomitant Administration of Ad26.RSV.preF/RSV preF Protein Vaccine and High-Dose Influenza Vaccine in Adults 65 Years and Older: A Noninferiority Trial.

  • Authors : Widagdo W; Janssen Vaccines and Prevention B.V., Leiden, The Netherlands.; Bastian AR

Subjects: Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/immunology ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/administration & dosage ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/adverse effects

  • Source: The Journal of infectious diseases [J Infect Dis] 2024 Aug 16; Vol. 230 (2), pp. e374-e383.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus.

  • Authors : Vieira Antão A; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.; Oltmanns F

Subjects: Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/prevention & control ; Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/immunology ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 Jun 21; Vol. 15, pp. 1376395. Date of Electronic Publication: 2024 Jun 21 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults.

Subjects: Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/immunology ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/administration & dosage ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/adverse effects

  • Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 May 15; Vol. 78 (5), pp. 1360-1368.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Maternal Tdap and influenza vaccination uptake 2017-2021 in the United States: Implications for maternal RSV vaccine uptake in the future.

  • Authors : Law AW; Pfizer, Inc., 66 Hudson Blvd East, New York, NY 10001, United States. Electronic address: .; Judy J

Subjects: Influenza, Human*/Influenza, Human*/Influenza, Human*/prevention & control ; Respiratory Syncytial Virus Vaccines* ; Diphtheria-Tetanus-acellular Pertussis Vaccines*

  • Source: Vaccine [Vaccine] 2023 Dec 12; Vol. 41 (51), pp. 7632-7640. Date of Electronic Publication: 2023 Nov 21.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

mRNA vaccines against respiratory viruses.

  • Authors : Whitaker JA; Department of Molecular Virology and Microbiology.; Department of Medicine.

Subjects: Influenza A Virus, H7N9 Subtype* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Influenza Vaccines*

  • Source: Current opinion in infectious diseases [Curr Opin Infect Dis] 2023 Oct 01; Vol. 36 (5), pp. 385-393. Date of Electronic Publication: 2023 Jul 18.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8809878 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice.

  • Authors : Pulkina A; Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia.; Vasilyev K

Subjects: Respiratory Syncytial Virus Infections* ; Influenza Vaccines* ; Influenza, Human*

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 14; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 14.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

February 2023 Updates of the Advisory Committee on Immunization Practices.

  • Authors : Gaviria-Agudelo C; Department of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, Florida, USA.; Yonts AB

Subjects: COVID-19* ; Influenza Vaccines* ; Respiratory Syncytial Virus Vaccines*

  • Source: Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2023 May 31; Vol. 12 (5), pp. 257-261.Publisher: Oxford University Press Country of Publication: England NLM ID: 101586049 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockade.

  • Authors : Geisen UM; Medical Department I, Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.; Rose R

Subjects: AIDS Vaccines* ; Antirheumatic Agents* ; COVID-19*/COVID-19*/COVID-19*/prevention & control SARS-CoV-2 variants

  • Source: Journal of medical virology [J Med Virol] 2022 Dec; Vol. 94 (12), pp. 5780-5789. Date of Electronic Publication: 2022 Aug 19.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.

  • Authors : Duan X; Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, People's Republic of China.; Zhang C

Subjects: Enterovirus*/Enterovirus*/Enterovirus*/genetics ; Hand, Foot and Mouth Disease*/Hand, Foot and Mouth Disease*/Hand, Foot and Mouth Disease*/epidemiology ; Hand, Foot and Mouth Disease*/Hand, Foot and Mouth Disease*/Hand, Foot and Mouth Disease*/prevention & control

  • Source: Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 2510-2519.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors.

  • Authors : Lu BN; School of Pharmacy, Minzu University of China, Beijing, China; Key Laboratory of Ethnomedicine (Minzu University of China), Ministry of Education, Beijing, China.

Subjects: AIDS Vaccines* ; COVID-19* ; Influenza Vaccines*

  • Source: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2022 Nov; Vol. 244, pp. 109103. Date of Electronic Publication: 2022 Aug 29.Publisher: Academic Press Country of Publication: United States NLM ID: 100883537 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  63 results for ""Respiratory Syncytial Virus Vaccines""